Monitoring Remyelination and Its Association With Disability Improvement in Multiple Sclerosis Using APART‐QSM: A Longitudinal Cohort Study
Journal of Magnetic Resonance Imaging · 27.10.2026
DOI: 10.1002/jmri.70601 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 27.10.2026. Verfasst von Zhuo Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Gansu Province Clinical Research Center for Functional and Molecular Imaging, National Natural Science Foundation of China, Science and Technology Program Project of Lanzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Background
Conventional MRI has limited specificity for myelin quantification. IterAtive magnetic suscePtibility sources sepARaTion quantitative susceptibility mapping (APART–QSM) quantifies myelin–sensitive (χ dia ) and iron–sensitive (χ para ) susceptibility components, but its value for longitudinal assessment of remyelination in multiple sclerosis (MS) remains unclear.
Purpose
To characterize longitudinal χ dia in MS and assess its associations with clinical characteristics. Study Type Prospective, longitudinal. Population One hundred forty–five patients with MS and 65 healthy controls (HCs). Field Strength/Sequence 3.0T; 3D T1 –weighted, 3D FLAIR , 3D DIR , and multi‐echo gradient‐echo imaging sequences. Assessment APART‐QSM generated χ dia and χ para maps, with susceptibility quantified in lesions and non–lesional regions, and the Expanded Disability Status Scale (EDSS) assessed at baseline and follow–up. Statistical Tests Chi–square, Mann–Whitney U, Wilcoxon signed–rank, Friedman tests, linear mixed‐effects models, linear and nonlinear regression. A p value < 0.05 was considered significant.
Results
One hundred one patients with MS and 20 HCs completed follow–up after a median (IQR) interval of 1.0 (0.8) and 1.25 (0.2) years, respectively. At baseline, white matter lesions (WMLs) exhibited lower χ dia (0.0131 [IQR 0.0087] ppm) and higher χ para (0.0058 [IQR 0.0049] ppm) than corresponding normal‐appearing white matter (NAWM) (0.0191 [0.0088] ppm; 0.0036 [0.0038] ppm; both p < 0.001). Over 1 year, χ dia in WMLs increased (0.0122 [IQR 0.0069] vs. 0.0152 [IQR 0.0065] ppm, p < 0.001), particularly in ofatumumab‐treated patients (0.0114 [IQR 0.0085] vs. 0.0158 [IQR 0.0081] ppm, p < 0.001). Greater increases in χ dia were significantly associated with female sex, ofatumumab treatment, relapsing–remitting phenotype, and EDSS improvement (all Bonferroni correction p < 0.01). Δχ dia showed a nonlinear decline with increasing disease duration (effective degrees of freedom ( edf ) = 1.83, p = 0.002).
Conclusion
APART–QSM may enable longitudinal monitoring of remyelination–related changes in MS, with declining Δχ dia over disease duration potentially informing individualized treatment strategies. Level of Evidence 2. Stage of Technical Efficacy 2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- Gansu Province Clinical Research Center for Functional and Molecular Imaging, Lanzhou, China.
- Deparment of Clinical & Technical Support, Philips Healthcare, Shanghai, China.
- Deparment of Clinical and Technical Support, Philips Healthcare, Xi'an, China.
- Department of Magnetic Resonance, The People's Hospital of Baoan Shenzhen, Shenzhen, Guangdong, China.
ORCID-Profile: Zhuo Wang, Mingsong Tang, Junye Yao, Guangyao Liu, Wenxia Yang, Yuping Han, Jing Zhang
Förderung
- Gansu Province Clinical Research Center for Functional and Molecular Imaging
- National Natural Science Foundation of China
- Science and Technology Program Project of Lanzhou Municipal Science and Technology Bureau
- Key R&D Plan of Gansu Province
- Lanzhou University Second Hospital "Cuiying Technology Innovation Plan" Applied Basic Research Project
Zitieren
APA
Wang, Z., Tang, M., Yao, J., Ai, K., Li, Y., Wang, J., Xu, X., Ren, W., Dang, W., Liu, G., Jiang, Y., Kang, S., Yang, W., Li, H., Yang, D., Han, Y., Liu, J., Jia, F., Jiang, J., …, & Zhang, J. (2026). Monitoring Remyelination and Its Association With Disability Improvement in Multiple Sclerosis Using APART‐QSM: A Longitudinal Cohort Study. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70601
Vancouver
Wang Z, Tang M, Yao J, Ai K, Li Y, Wang J, et al. Monitoring Remyelination and Its Association With Disability Improvement in Multiple Sclerosis Using APART‐QSM: A Longitudinal Cohort Study. Journal of Magnetic Resonance Imaging. 2026. doi:10.1002/jmri.70601
BibTeX
@article{Wang2026,
author = {Wang, Zhuo and Tang, Mingsong and Yao, Junye and Ai, Kai and Li, Yujing and Wang, Jun and Xu, Xia and Ren, Wenjing and Dang, Wenzhu and Liu, Guangyao and Jiang, Yanli and Kang, Siru and Yang, Wenxia and Li, Hao and Yang, Dan and Han, Yuping and Liu, Jinrui and Jia, Fei and Jiang, Jingqi and Ding, Yucheng and Zhang, Jing},
title = {Monitoring Remyelination and Its Association With Disability Improvement in Multiple Sclerosis Using APART‐QSM: A Longitudinal Cohort Study},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
doi = {10.1002/jmri.70601}
}
EUVIMED